FDA Approves First Generic Xofluza for Flu Treatment and Prophylaxis
On June 17, 2026, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xofluza, the brand‑name antiviral baloxavir marboxil, for use in patients five years of ...
Read story →